February 22nd, 2012
Part 5: Clashing Views of Appropriate Use Criteria for PCI
Paul S. Chan, MD, MS, Steve Marso, MD, John Spertus, MD, MPH and J Aaron Grantham, MD, FACC
In a recent Viewpoint in JACC: Cardiovascular Interventions, Marso and colleagues expressed grave reservations about the application of appropriate use criteria for PCI in a controversial study published last year in JAMA by Chan and colleagues, which found that only half of PCIs performed for nonacute indications were classified as appropriate. Interventional cardiology editors Rick Lange and David Hillis asked CardioExchange members for their […]
February 21st, 2012
Selections from Richard Lehman’s Weekly Review: Week of February 20th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include LVH, pollution and MI, the genetics of cardiomyopathy, atrial fibrillation, and aspirin for primary prevention.
February 21st, 2012
More Rigorous Assessment of Family History Improves CV Risk Determination
Larry Husten, PHD
Although family history has long been recognized as an important cardiovascular risk factor, usual methods to assess risk have not incorporated family history in a rigorous manner. A new study published in the Annals of Internal Medicine finds that systematically collecting family history in a primary practice setting significantly increases the identification of high-risk people. Nadeem Qureshi […]
February 21st, 2012
Part 4: Clashing Views of Appropriate Use Criteria for PCI
Steve Marso, MD, J Aaron Grantham, MD, FACC, Paul S. Chan, MD, MS and John Spertus, MD, MPH
In a recent Viewpoint in JACC: Cardiovascular Interventions, Marso and colleagues expressed grave reservations about the application of appropriate use criteria for PCI in a controversial study published last year in JAMA by Chan and colleagues, which found that only half of PCIs performed for nonacute indications were classified as appropriate. Interventional cardiology editors Rick Lange and David Hillis asked CardioExchange members for their […]
February 17th, 2012
Part 3: Clashing Views of Appropriate Use Criteria for PCI
John Spertus, MD, MPH, Steve Marso, MD, J Aaron Grantham, MD, FACC and Paul S. Chan, MD, MS
In a recent Viewpoint in JACC: Cardiovascular Interventions, Marso and colleagues expressed grave reservations about the application of appropriate use criteria for PCI in a controversial study published last year in JAMA by Chan and colleagues, which found that only half of PCIs performed for nonacute indications were classified as appropriate. Interventional cardiology editors Rick Lange and David Hillis asked CardioExchange members for their […]
February 16th, 2012
Japanese Researcher with Harvard Connections Retracts 3 Articles in AHA Journals
Larry Husten, PHD
Akio Kawakami, a well-published lipid researcher at Tokyo Medical and Dental University, has retracted three papers from AHA journals, including one article in the AHA’s flagship journal Circulation. The two other retractions were for articles in Circulation Research and Arteriosclerosis, Thrombosis, and Vascular Biology. News of the retractions was first reported on Retraction Watch. Two of Kawakami’s co-authors are well known researchers affiliated […]
February 16th, 2012
Part 2: Clashing Views of Appropriate Use Criteria for PCI
J Aaron Grantham, MD, FACC, John Spertus, MD, MPH, Steve Marso, MD and Paul S. Chan, MD, MS
In a recent Viewpoint in JACC: Cardiovascular Interventions, Marso and colleagues expressed grave reservations about the application of appropriate use criteria for PCI in a controversial study published last year in JAMA by Chan and colleagues, which found that only half of PCIs performed for nonacute indications were classified as appropriate. Interventional cardiology editors Rick Lange and David Hillis asked CardioExchange members for their […]
February 16th, 2012
What Are the Lessons of the Riata ICD Lead Recall?
Edward J. Schloss, MD
Let’s enforce a robust, active postmarket surveillance system that will allow doctors in the field to draw their own conclusions about the safety of devices based on much better data without hampering innovation.
February 15th, 2012
AHA Scientific Statement Spotlights Peripheral Artery Disease in Women
Larry Husten, PHD
Although peripheral artery disease (PAD) raises the risk for heart disease and stroke, it often goes undiagnosed and untreated, especially in women, according to a scientific statement issued by the American Heart Association and published in Circulation. Here are a few highlights of the statement: Although women develop PAD later than men, the total number of women […]
February 15th, 2012
Part 1: Clashing Views of Appropriate Use Criteria for PCI
Paul S. Chan, MD, MS, J Aaron Grantham, MD, FACC, Steve Marso, MD and John Spertus, MD, MPH
In a recent Viewpoint in JACC: Cardiovascular Interventions, Marso and colleagues expressed grave reservations about the application of appropriate use criteria for PCI in a controversial study published last year in JAMA by Chan and colleagues, which found that only half of PCIs performed for nonacute indications were classified as appropriate. Interventional cardiology editors Rick Lange and David Hillis asked CardioExchange […]